Thomas Sciascia, Chief Scientific Officer: Trevi Therapeutics TRVI Sell · Filed 24/08/21

Trade details

Type: Insider sale
Amount: $48,828.16
Shares · price: 16,496 sh · $2.96 a share
Held after: 220,315 sh
Stock: Trevi Therapeutics TRVI
Person: Thomas SciasciaChief Scientific Officer
Trade date: 24/08/19
Filed: 24/08/21
Days to filing: 2 days

Sold 7.0% of holdings

Share of holding sold: 7.0%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

Thomas Sciascia's recent trades

Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$17.4K
2,631 sh
$17.4K
Filed 25/03/26
Traded 25/03/25
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$51.5K
18,660 sh
$51.5K
Filed 24/08/16
Traded 24/08/16
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$35.6K
12,745 sh
$35.6K
Filed 24/08/16
Traded 24/08/15
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$275
100 sh
$275
Filed 24/08/16
Traded 24/08/14
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$136.1K
53,368 sh
$136.1K
Filed 24/05/31
Traded 24/05/29